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Abstract
The General Optical Council has recently clarified the legal position for eye care practitioners wishing to use lissamine green dye for anterior 
eye examination. This paper reviews the history and current use of the dye in ocular examination. Though data are limited, the dye is found 
to be well tolerated by patients when used in strip form. Recommendations are made on the optimum use of the dye based on published 
research and its unique staining properties are discussed. 
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Introduction
The use of dyes in ophthalmology dates 
back to the 1800s when a method of 
‘vital staining’ was used to stain cells and 
tissues in their living state.1 The three vital 
ocular dyes that are used in examination 
of the anterior eye are sodium fluorescein, 
lissamine green (LG) and rose Bengal. 
Lately, the use of LG in optical practice 
has been recommended by researchers 
and key opinion leaders alike, particularly 
in the investigation of dry eye.2 However, 
until March 2020 the legality of eye care 
practitioners using the dye in the UK 
was unclear. This paper seeks to review 
the historical and current uses of LG, 
trace the changes to its legal position 
in the UK, examine the safety profile of 
the dye, consider how best to optimise 
its use in optical practice and discuss 
the advantages of using LG in addition 
to sodium fluorescein in anterior-eye 
assessment.
Origin and history of  
lissamine green
LG, chemical formula C27H25N2NaO7S2, is 
a synthetically produced, non-fluorescent, 
organic dye, a diphenyl-naphthyl methan 
derivative of the phenylmethane dye 
and also known as ‘wool green S’ or ‘fast 
light green’. It has been approved by the 
US Food and Drug Administration as a 
colour additive in food and cosmetics.1 
The first recorded use of LG as a staining 
agent was for proteins in the process of 
electrophoresis in 1957.3,4
In 1967, LG was initially recognised for 
its ocular use in the determination of 
endothelial cell viability.5 However, it was 
Norn,6 in 1973, who described its use as 
a vital dye for staining of the cornea and 
conjunctiva, highlighting that it stains 
degenerate cells, dead cells and mucus, 
with staining properties very similar to 
those of rose Bengal. 
In subsequent years, LG was suggested for 
the clinical diagnosis of xerophthalmia, 
though it was shown to lack the required 
sensitivity,7 and for the assessment of 
epithelial damage in cataract surgery.8
Despite these occasional applications, 
LG was not widely utilised until the mid-
1990s when Tseng9 confirmed Norn’s 
findings and affirmed that LG would not 
stain healthy cells, but was ideal for the 
detection of dead or degenerate cells.
The recommendation of the use of LG in 
the Tear Film and Ocular surface Society 
(TFOS) Dry Eye WorkShop (DEWS) I 
report10 in 2007 helped establish LG as an 
important dye in the repertoire of testing 
regimes used to evaluate dry-eye disease, 
and this has been further reinforced with 
publication of the TFOS DEWS II report. 
Additionally, the Optician magazine 
published a CET-accredited article on LG 
in 2010, which suggested the dye was 
becoming more widespread in clinical 
practice in the UK.11
The legal position in the UK
At a time when LG was gaining greater 
acceptance as a clinically useful dye, 
uncertainties were raised over the legality 
of its use in the UK. To fully understand 
this legal situation, the problems which 
arose over the legality of fluorescein strips 
must be examined initially.
A series of EU directives from 1994 (which 
are now in the process of being reviewed) 
have previously defined the role and 
purpose of what constitutes a ‘medicine’ 
in comparison to a ‘medical device’. Under 
these directives a medicine or medicinal 
product is ‘A substance … that is intended 
to treat, prevent or diagnose a disease’.12 
Within the UK, fluorescein is licensed 
as a Pharmacy (P) medicine, meaning it 
can be legally used by an optometrist or 
contact lens optician during the course of 
professional practice.  
In 2013, Bausch & Lomb withdrew its 
fluorescein-impregnated strips, known as 
Fluorets, from the market; at the time, 
these were the only impregnated strips 
licensed as a P medicine for use in the UK. 
As a result, practitioners had no option 
but to use 1% or 2% fluorescein 
Minims for clinical practice – the only 
appropriately licensed products in the UK. 
The use of Minims has several problems, 
including difficulties in controlling the 
amount of fluorescein instilled into the 
eye. Moistened fluorescein strips are 
often more appropriate for clinical use 
in optometric or contact lens-related 
practice where only a small amount 
of dye is required. If the concentration 
of fluorescein is too high, it can delay 
assessment by 2–4 minutes, until the 
concentration has reduced to a useful 
level. The use of 2% Minims or saturated 
strips (saline not shaken off) can result in 
these excessive concentrations.13 Given 
that a 1% Minim or moistened strip 
provided a useful level of fluorescence 
quickly, the cost-effectiveness of 
fluorescein strips makes them a good 
choice in clinical practice.14 However, as 
the only available CE-marked fluorescein 
strips were classified as ‘medical devices’ 
in Europe, there was considerable 
ambiguity over whether practitioners in 
the UK could legally use the strips as an 
alternative. Medical devices are defined 
as ‘products or equipment intended 
generally for a medical use’.15 In response 
to lobbying from the profession, the 
Medicines and Healthcare Products 
Regulatory Agency (MHRA) has agreed 
not to prevent the supply of CE-marked 
medical device fluorescein strips to the 
UK market until its status has been agreed 
by the EU.16
Subsequently, and following expert legal 
advice and consultation with an expert 
clinical consensus panel, the General 
Optical Council (GOC) issued a statement 
on 30 September 2013 clarifying the 
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circumstances in which optometrists and 
contact lens opticians can use CE-marked 
fluorescein ophthalmic strips, to the effect 
that:17
•  registrants are responsible for acting 
in their patients’ best interests, in line 
with the GOC Code of Conduct; and
•  acting in patients’ best interests, as 
required by the Code of Conduct, may 
make it necessary for registrants to 
use CE-marked strips (the marketing 
and supply of which are not currently 
opposed by the MHRA), where they are 
acting within their scope of practice.
The guiding principle quoted by the 
GOC was that optometrists and contact 
lens opticians should act in the best 
interests of patients and in doing so it was 
therefore appropriate to use CE-marked 
fluorescein strips.17 
Clarification around the use of LG was 
not included in the 2013 GOC statement 
because LG, unlike fluorescein, did not 
have P medicine status but was licensed 
as a medical device in the UK. This 
resulted in a situation in the UK where 
(from 2013 to 2020) some practitioners 
chose to use LG, effectively ‘off-label’, 
whereas others were reticent to use it at 
all.
In 2016, the UK College of Optometrists 
issued a statement, highlighting that it 
did not advocate the use of LG, citing 
the GOC statement on fluorescein.18 
Without a GOC and MHRA statement the 
College of Optometrists could not ensure 
clinicians would not face regulatory 
action. The College then continued to 
lobby for a regulatory statement along 
with the Association of Optometrists and 
other industry stakeholders. 
Following requests from UK optical 
professional bodies, the GOC formed 
a panel of academics/researchers and 
experienced eye care practitioners to help 
clarify the legal position of LG. The panel 
met in April 2018 and they unanimously 
agreed that:
  based on the evidence available and 
practice and clinical opinion, lissamine 
green is clinically safe to use and that 
optometrists and contact lens opticians 
in the UK may, within their scope of 
practice, use a CE marked lissamine 
green impregnated ophthalmic strip 
for clinical investigations of the ocular 
surface until further notice.19 
Despite this, regrettably it was to be 
almost 2 years before the GOC finally 
published its position statement on 
LG use in March 2020.19 In light of the 
clarification by the GOC, the College 
of Optometrists’ Director of Policy and 
Strategy has stated: ‘Our members will 
welcome the news that they can use CE-
marked lissamine green ophthalmic strips 
in appropriate clinical circumstances.’20 
The timeline from 2013 to the present 
day is summarised in Figure 1.
As with fluorescein, LG strips have 
been CE-marked in EU member states 
as medical devices. While the MHRA 
maintains the strips should be regulated 
as a medicinal product, they have 
indicated that they will refrain from taking 
any regulatory action against the use of 
such strips. Having considered the panel’s 
report and the MHRA’s stance the GOC 
position states:
  [We] consider that there will be 
circumstances where it is necessary, 
in the patient’s best interests, for 
optometrists and contact lens opticians 
to use CE-marked lissamine green 
ophthalmic strips ... within the scope of 
their practice.19
An explanation of the patient’s best 
interests may be found in the GOC 
statement, which makes the following 
recommendation: 
  Registrants are individually responsible 
for acting at all times in the best 
interests of their patients, and must 
determine the most appropriate clinical 
care in accordance with the GOC’s 
Standards of Practice for Optometrists 
and Dispensing Opticians.19 
This position was further supported by 
the Association of Optometrists and their 
clinical director: 
  This pragmatic approach will mean 
that optometrists and contact lens 
opticians, who deem lissamine green 
the most appropriate way to assess their 
patient’s eye health, can do so without 
being concerned that they may face 
regulatory action.21 
In summary, to understand the legal 
position regarding the use of ophthalmic 
dyes in the UK, it should be recognised 
that, whilst it is possible to purchase, 
and use, fluorescein and LG-impregnated 
strips, these do not currently have a UK 
medicinal licence. However, the GOC and 
MHRA statement gives the reassurance 
that practitioners can use fluorescein 
and LG without the prospect of facing 
regulatory action. 
Reporting of adverse events 
with lissamine green
The ocular surface’s tolerance to LG strips 
is high but can be lower in individuals 
with dry-eye disease.22,23 Lower tolerance 
has also been reported when using higher 
concentrations of LG solution.24,25 
While a handful of studies have reported 
no significant adverse effects from the use 
of LG,8,26,27 including two studies which 
used a 1% LG concentration,8,26 many 
others have simply not included these 
data.28-35 
Several studies have specifically 
investigated the tolerance of LG on the 
ocular surface. Manning et al.23 compared 
Figure 1. Timeline from 2013 to present day, summarising the legal position of the use of fluorescein and lissamine 
green CE-marked strips. 
March  
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•   MHRA permits CE-marked fluorescein strips to be supplied in the UK (even 
though they were licensed as ‘medical devices’)
•   GOC statement issued saying it is appropriate to use CE-marked fluorescein 
strips when in the best interests of the patient
2016  •   Guidance sought on similar use of CE-marked lissamine green strips 
 •   College of Optometrists issues statement advising against the use of lissamine 
green as the GOC statement on fluorescein does not apply
April  
2018




•   GOC statement issued saying it is appropriate to use CE-marked lissamine 
green strips when in the best interests of the patient
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tolerance following instillation of a single 
drop of LG 1% and rose Bengal 1% in 
patients with keratoconjunctivitis sicca  
(n = 12) and those without (n = 8). 
Dry-eye patients reported slightly more 
stinging with LG than non-dry-eye 
patients. However, LG was found to be 
significantly more comfortable than 
rose Bengal in both groups, without 
compromising the quality of the ocular 
surface assessment. This paper also 
highlighted that the duration of any 
discomfort was significantly shortened 
with LG compared to rose Bengal. 
Similarly, Khurana et al.22 used LG in their 
study to examine the tear film profile in 
dry-eye suspects (n = 100), though both 
the concentration of the dye and whether 
a prepared solution or strip was used is 
unclear. Of the dry-eye subjects included 
in the study, 41% found LG irritating, 
but this reduced to 22% in the control 
group of non-dry-eye subjects. This is 
compared to irritation in 92% and 49% of 
subjects in the dry-eye and control groups 
respectively with rose Bengal.  
Korb et al.24 explored patient experience 
following a combination of different types 
of dye in different concentrations in eyes 
affected by ocular surface disease. The 
results indicated that 1% LG resulted in 
no adverse sensation but burning and 
discomfort were experienced with the 2% 
or 3% concentrations. 
A recent Australian study by Delaveris 
et al.25 investigated the performance 
of four different brands of LG strips 
and calculated the concentration of LG 
created from each strip when dipped 
into 200 µL of sterile saline for 1 minute. 
The concentrations ranged from 0.5% 
to 4.9%. Staining intensity was greater 
with higher concentrations of LG (brands: 
Green Glo, Hub Pharmaceuticals, USA and 
OP Green, Surgitech Innovation, India, 
4.9% and 3.4% respectively). The pH of 
the stained saline was also measured for 
each of the four brands and the results 
ranged from 6.26 to 6.75. None of the 22 
volunteers reported any discomfort and 
the researchers reported that the range of 
pH measured would not be expected to 
cause ocular surface burns or stinging.
It is also important to remember that 
if any adverse events do occur in the 
course of optometric practice they can 
be reported via the MHRA’s yellow 
card scheme. This can now be completed 
online by eye care practitioners (https://
yellowcard.mhra.gov.uk/). At the time 
of writing, to the best of the authors’ 
knowledge, no adverse events associated 
with LG had been reported to the MHRA 
through their yellow card system.
Toxicity
Chodosh et al.36 showed no significant 
cellular toxicity and no effect on cell 
viability when an assay was conducted that 
had previously shown toxicity with rose 
Bengal. In this assay the corneal epithelial 
cells were exposed to the dye  
for 5 minutes then washed away with 
buffer in a method designed to mimic the 
natural tearing that would occur in humans. 
Pilot research37 involving the analysis 
of corneal cells from five participants 
following repeated  
instillations of 0.5% LG (up to six 
instillations) showed no significant  
increase in cell death.
Optimum use of  
lissamine green
LG has been shown to have a similar 
staining pattern to rose Bengal, but it 
is much better tolerated by patients.24 
Its best efficacy is in the examination 
of conjunctival staining, while sodium 
fluorescein remains the most suitable dye 
for the visualisation of corneal staining.2 
The visualisation of ocular changes in highly 
vascularised areas, such as those found in 
lid wiper epitheliopathy (LWE), is easier 
with LG compared to fluorescein because 
the green dye provides excellent contrast 
against the red marginal and palpebral 
conjunctiva,38 as shown in Figure 2.  
Efron et al.39 highlighted that LG is the 
most commonly used dye throughout the 
literature for assessing LWE. 
Concentrations of at least 1% LG are 
recommended to optimise visualisation 
of the staining patterns.40 Variations may 
be introduced due to the brand of strip 
and amount of saline used. A study of LG 
strips found that the concentrations of 
BioLissamine (Biotech Healthcare Group, 
India) and Lissaver (Dina-Hitex Spol, Czech 
Republic) came in at under 1% (being 
0.9% and 0.5% respectively).25 Therefore, 
the TFOS recommend waiting 5 seconds 
once the strip has been wetted with a full 
drop of saline to elute the dye and then 
ensure a full drop is instilled on to the 
ocular surface from the strip, as opposed 
to shaking the solution off the strip as 
you would with fluorescein. This should 
maximise the viewing of any staining.2  
Further discrepancies may arise depending 
on how long practitioners wait to examine 
staining patterns following instillation. 
The ocular surface should be examined 
between 1 and 4 minutes post-instillation 
of the dye. If the surface is examined 
too soon, any staining pattern present 
may not have had adequate time to 
develop fully. After about 4 minutes the 
staining pattern has been found to fade.40 
Foulks40 recommends starting with a low 
illumination and increasing the brightness 
until the appearance of any staining is 
optimum. Examining staining patterns 
under light that is too bright can reduce 
the contrast of the pattern, making it 
more difficult to fully evaluate. The use 
of a red barrier filter in the observation 
system of the slit lamp has been shown 
to significantly improve visualisation of 
staining.26 
Figure 2. (a) Marx’s line stained with lissamine green and (b) lid wiper epitheliopathy stained with lissamine green. 
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For the optimum visualisation of LWE 
two instillations of LG with two separate 
strips, 1 minute apart, are recommended 
followed by viewing between 3 and 5 
minutes after the second instillation.38 
The method for using LG was clearly 
outlined by the TFOS; see Table 1 for this 
step-by-step method.2 
When assessing the anterior eye there 
will be occasions when clinicians wish 
to utilise both fluorescein and LG dyes 
because of their respective benefits for 
observation of corneal and conjunctival 
staining. Within the published literature 
there appears to be little consensus 
regarding any definitive protocol for use 
in such instances. Research does highlight 
that sequential staining and/or using 
more than one strip will increase the 
likelihood of observing ocular surface 
damage.42 The DEWS II report summed up 
the use of LG and fluorescein: 
  while corneal staining is perhaps a 
later stage feature of DED [dry eye 
disease], combination staining with 
fluorescein and lissamine green 
instilled by moistened and saturated 
filter paper strip to highlight corneal 
and conjunctival / eyelid margin tissue 
damage is recommended as the most 
appropriate diagnostic technique for 
evaluating ocular surface damage.2 
Korb et al.24 used a mixture of 2% 
fluorescein with 1% LG and found 
that the fluorescent characteristics of 
fluorescein were not altered by the 
addition of LG. If dyes are instilled in 
paper form it would be impossible to 
guarantee that the fluorescein was 
at twice the concentration of LG. The 
importance of this ratio of concentrations 
has not been investigated. 
A study by Bron et al.43 examined the 
characteristics of fluorescein, LG and 
rose Bengal in detail. They found that 
the properties of LG and fluorescein 
differ in many ways. LG has a higher 
molecular mass and binds more strongly 
to a cell nucleus than fluorescein. The 
ideal concentration of fluorescein for 
viewing is about 0.1%, which is 10 times 
less than a 1% concentration of LG (the 
minimum recommended concentration). 
The diffusion gradient would mean 
that LG (at the higher concentration) 
would be more likely to enter a cell. 
Conversely, fluorescein’s lower molecular 
mass increases its likelihood of entering 
the cell. Once in the cell LG would bind 
more strongly to the cell nucleus than 
fluorescein. Although Korb et al.24 have 
advocated the simultaneous instillation 
of the two dyes, given their different 
chemical properties, sequential instillation 
may be better. 
Six studies reported instilling fluorescein 
prior to the instillation of LG;31,33,35,41,44,45 
however none of the methodologies 
describe the rationale for this order. 
Guillon and Maissa46 instilled LG before 
fluorescein, but similarly there is no 
explanation as to why this order was 
chosen. In a case report by Maldonaldo-
Codina et al.,47 the staining was examined 
firstly using fluorescein followed by LG 
at one visit and then the order of dye 
instillation was reversed at a subsequent 
visit (on a separate day). The authors 
found that the order in which the dyes 
were instilled did not have any impact 
on the staining pattern, but it should be 
noted this case report examined only 
four eyes of two patients.47 Accordingly, 
current literature does not appear to 
provide unambiguous clinical guidance on 
a recommended order of instillation when 
utilising both fluorescein and LG to assess 
potential ocular surface damage to both 
the cornea and conjunctiva.
Does lissamine green enhance 
the investigation of ocular 
surface staining?
Originally, rose Bengal was used to 
visualise conjunctival staining, but its 
potential adverse impact on healthy 
corneal cells48 and poor tolerance by 
some patients (in particular those 
with dry eye)22,24 led clinicians to seek 
better-tolerated alternatives such as LG.6 
However, if an eye care practitioner is 
already using sodium fluorescein dye, is 
there any benefit to also using LG?
Korb et al.24 compared corneal and 
conjunctival staining detected by 
rose Bengal, fluorescein, LG and 
combinations thereof in a small cohort 
of 14 participants. The best efficacy 
was found with a mixture of rose 
Bengal and fluorescein.  However, as 
rose Bengal is not well tolerated, the 
authors recommended using a mixture 
of fluorescein and LG, which they found 
to be more efficacious than fluorescein 
alone, particularly with respect to 
conjunctival staining. More recent 
supportive evidence for LG use was 
reported for a larger cohort (n = 50) 
where LG conjunctival staining was found 
to be one of the most sensitive metrics 
for assessing the treatment effects of 
artificial tears.45
The need for using a combination of dyes 
was demonstrated in a study designed 
to examine the relationship between 
lid margin staining and sensitivity. 
Researchers used both fluorescein and 
LG to examine the margins for staining 
on 27 eyes of 27 subjects.41 The final 
staining score used for comparison with 
sensitivity was whichever was the highest 
(the fluorescein staining score or the 
LG staining score). The paper does not 
indicate which dye gave the highest score 
either on individual subjects or in general, 
but the use of both dyes was deemed 
necessary to elicit the full extent of lid 
margin staining.
Table 1. Step-by-step guide to the use of lissamine green (LG) 
The Tear Film and Ocular surface Society guidelines for LG instillation should also be 
followed,2 namely:
 •   For instillation, wet the LG strip with saline, with the whole drop retained on the strip for at least 
5 seconds to elute the dye
 •   10 µL, or ¼–½ drop, appears optimal volume if pipetting a specific concentration
 •   The drop is instilled inside the lower temporal lid on upgaze with the eyelid pulled temporally to 
avoid damage to the conjunctiva or lid wiper tissue 
 •   Observation should occur between 1 and 4 minutes post-instillation,40 with use of a red filter to 
potentially aid visualisation29
 •   For lid wiper epitheliopathy, assessment involves repeat instillation of LG using two separate 
strips, wetting with two saline drops, with viewing recommended after 3–6 minutes41
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Additionally, a study investigating 
conjunctival staining and its association 
with dry-eye symptoms applied LG 
followed by fluorescein on the conjunctiva 
of non-contact lens wearers (72 subjects) 
and soft contact lens wearers (102 
subjects).46 The authors found that, in 
the non-contact lens wearers, higher 
levels of both fluorescein and LG staining 
were associated with increased dry-eye 
symptoms. However, in the soft contact 
lens wearers, only LG staining acted as a 
discriminant between the symptomatic 
and non-symptomatic dry-eye patient, 
indicating its usefulness in this patient 
group and the benefits of using both dyes 
routinely in clinical practice.
In 2015, Eom et al.44 examined 
conjunctival staining as imaged with 
LG and the same staining imaged with 
fluorescein and a yellow barrier filter.  
The authors concluded that fluorescein 
with the filter was more effective than 
LG. However, the sample size was small 
(13 eyes of 13 subjects), no barrier filter 
was used to view the LG staining and 
effectivity was based on the extent of 
staining shown by each dye. The authors 
do concede that the two dyes stain 
slightly different cell types.
In a case report of solution-induced 
corneal staining (SICS), researchers 
found that LG staining corresponded 
closely to the white-light observations 
of SICS, whereas fluorescein staining 
was more extensive.47 This case report 
only included four eyes of two subjects. 
It was speculated that the larger area 
observed with fluorescein might be due to 
it diffusing laterally within the epithelial 
tissue, or it may be due to fluorescein 
binding to preservatives from contact 
lens care solutions which are dispersed 
across the epithelial surface. The authors 
suggested that the use of more than one 
type of ophthalmic dye may be useful in 
understanding the underlying mechanism 
of this phenomenon.
In the first DEWS report in 2007, it was 
noted that fluorescein diffuses rapidly into 
tissue and therefore any staining observed 
with fluorescein must be graded quickly.10 
LG staining, however, persists for longer, 
which is particularly advantageous for 
grading and photography. In addition, the 
TFOS DEWS II pathophysiology report 
in 2017 also highlights that corneal 
filaments stain particularly well with 
LG (Figure 3).49 There is no mention of 
fluorescein in relation to the staining of 
filaments. Furthermore, a recent study 
examining possibilities of differentially 
diagnosing Sjögren’s dry eye from non-
Sjögren’s found that bulbar conjunctival 
LG staining was significantly higher 
in patients with Sjögren’s dry eye.50 
It should be noted that it is still not 
conclusive as to exactly how LG interacts 
with living cells and therefore there is still 
a degree of uncertainty as to what LG 
staining actually represents.
Summary
The GOC has made clear that LG may 
be used where it is in ‘the patient’s best 
interests’19 and optometrists and contact 
lens practitioners in the UK can be 
assured that no regulatory action will be 
taken for use of an LG strip in ‘appropriate 
clinical circumstances’.20
This paper has highlighted studies 
which show that LG stains differently to 
fluorescein10,41,44,47,49,51 and several studies 
in which the authors recommend the use 
of LG as an adjunct to fluorescein.2,24,46,47
In regard to safety, with the exception of 
one study,22 in which the concentration 
and form of LG used were unclear, the 
evidence suggests prepared solutions 
of LG can cause minor ocular irritation 
even at concentrations as low as 1% 
but significantly less irritation than with 
rose Bengal.6,22 By comparison, there 
does not appear to be irritation from 
LG instilled into the eye via strips, even 
with concentrations as high as 4.9%.25 
A possible reason for this may be that 
the additives in the dye to keep the strip 
sterile have the fortunate side effect of 
improved patient tolerance to the dye. 
Alternatively, it could be hypothesised 
that the irritation reported from LG 
solutions may be related to the solvent 
used to create the solutions. Delaveris 
et al.25 demonstrated that not all LG 
strips produce the same concentration 
of dye once wetted, thus it may be more 
difficult to visualise staining when the dye 
is in lower concentrations. Practitioners, 
therefore, ought to exercise caution when 
selecting LG strips. 
Based on the evidence above, and 
consistent with the GOC statement, the 
recommendation of this review would be 
for eye care practitioners who wish to use 
LG to examine conjunctival staining to 
continue doing so with LG-impregnated 
paper strips (LG in solution form is not 
currently available in the UK, to the 
best of the authors’ knowledge), using 
an approved protocol or methodology 
as described previously. Optometrists 
and contact lens opticians who have 
previously been hesitant or reluctant to 
use it should now feel confident using 
it with the GOC’s backing and renewed 
understanding of its applications. 
Fluorescein would still be required, and 
is preferable, as a staining agent for the 
cornea.24,51 
Figure 3. Corneal filament stained with lissamine green. (Courtesy of Sarah Farrant.)
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Conclusion
Given the growing evidence base on the use of LG, its benefits to 
clinical practice and tolerability, the clarification from the GOC 
should serve as reassurance for practitioners wishing to use LG in 
routine practice, particularly in the investigation of dry eye. The 
summary from the MHRA as published by the GOC is as follows: 
  The MHRA accepts that there may be instances where companies 
may supply lissamine green ophthalmic strips that have been 
CE-marked in EU member states, and has said that at the present 
time, no regulatory action will be taken against strips that are 
CE-marked as medical devices. 
  Providing that the product being used is CE-marked the current 
lack of licensing in the UK should not prevent optometrists and 
contact lens opticians from using lissamine green in clinical 
practice.19
Although there is a general consensus that there are likely to be 
minimal adverse effects from LG use in strip form, establishing a 
larger evidence base could help to better inform clinical decisions. 
Whilst some questions remain unanswered with regard to the 
availability and the performance of differing strips, evidence 
indicates that LG plays a valuable role in aiding our evaluation and 
understanding of ocular surface damage and as such it should be 
viewed as in the patient’s best interest to utilise such techniques.
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Relevance to practice 
•  This paper explains the advantages of using LG dye in 
conjunction with fluorescein as part of any anterior-eye 
assessment
•  Recommendations are made to use LG in strip form 
rather than in solution
• The safety profile of lissamine green is reviewed
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CPD exercise 
After reading this article, can 
you identify areas in which your 
knowledge of lissamine green has 
been enhanced?
How do you feel you can use this 
knowledge to offer better patient 
advice?
Are there any areas you still feel 
you need to study and how might 
you do this?
Which areas outlined in the 
article would you benefit from 
reading in more depth, and why?
CET multiple choice questions
 
This article has been approved for one 
non-interactive point under the GOC’s 
Enhanced CET Scheme. The reference  
and relevant competencies are stated  
at the head of the article. To gain your 
point visit the College’s website  
college-optometrists.org/oip and complete 
the multiple choice questions online. The 
deadline for completion is 31 July 2021. 
Please note that the answers that you will 
find online are not presented in the same 
order as in the questions below, to comply 
with GOC requirements. 
1.  According to a study by Delaveris 
et al., which brand of lissamine 
green strip produced the highest 
concentration of dye?
 • Green Glo
 • Biotech
 • OP Green
 • Lissaver
2.  Staining patterns visualised using 
lissamine green should be viewed:
 •  Immediately post-instillation of the 
lissamine green dye
 •  Using a red barrier filter in the 
observation system of the slit lamp
 •  Five minutes post-instillation of the 
lissamine green dye
 •  Using a yellow barrier filter in the 
observation system of the slit lamp
3.  Lissamine green has similar 






4.  The guiding principle of the GOC is 
that practitioners should:
 •  Keep all invasive tests to an 
absolute minimum
 •  Only use non-CE-marked dyes 
where a CE-marked equivalent is 
unavailable
 •  Follow best international practice 
when in doubt
 •  Act in the best interests of the 
patient
5.  Which of the following is a 
guideline from TFOS regarding the 
best technique for using lissamine 
green?
 •  Dip the lissamine green strip into 
saline for about a minute
 •  Place the dye on the superior 
bulbar conjunctiva to examine tear 
dynamics
 •  Check for staining immediately 
post-instillation
 •  Instil two wetted strips of lissamine 
green to check for lid wiper 
epitheliopathy
6.  Which of the following is true 
regarding the examination of 
solution-induced corneal staining 
(SICS) according to a 2013 case 
report?
 •  SICS is best examined exclusively 
with fluorescein
 •  SICS is best examined exclusively 
with rose Bengal
 •  SICS is best examined with a 
combination of stains
 •  Lissamine green can cause an 
apparent increase in staining area in 
SICS
